Neon Therapeutics SEC Filings https://ir.neontherapeutics.com/ Neon Therapeutics SEC Filings en 10-Q: Quarterly report which provides a continuing view of a company's financial position https://ir.neontherapeutics.com/sec-filings/sec-filing/10-q/0001694187-19-000038 Neon Therapeutics, Inc. Mon, 13 May 2019 09:07:16 -0400 Neon Therapeutics SEC Filings 7121 8-K: Report of unscheduled material events or corporate event https://ir.neontherapeutics.com/sec-filings/sec-filing/8-k/0001694187-19-000036 Neon Therapeutics, Inc. Mon, 13 May 2019 08:49:13 -0400 Neon Therapeutics SEC Filings 7116 DEFA14A: Additional proxy soliciting materials - definitive https://ir.neontherapeutics.com/sec-filings/sec-filing/defa14a/0001694187-19-000031 Neon Therapeutics, Inc. Fri, 26 Apr 2019 09:02:39 -0400 Neon Therapeutics SEC Filings 7096 DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") https://ir.neontherapeutics.com/sec-filings/sec-filing/def-14a/0001694187-19-000030 Neon Therapeutics, Inc. Fri, 26 Apr 2019 09:00:38 -0400 Neon Therapeutics SEC Filings 7091 CT ORDER: CT ORDER https://ir.neontherapeutics.com/sec-filings/sec-filing/ct-order/9999999997-19-001424 Neon Therapeutics, Inc. Tue, 19 Mar 2019 10:13:48 -0400 Neon Therapeutics SEC Filings 7051 S-8: Securities offered to employees pursuant to employee benefit plans https://ir.neontherapeutics.com/sec-filings/sec-filing/s-8/0001694187-19-000027 Neon Therapeutics, Inc. Mon, 11 Mar 2019 17:30:57 -0400 Neon Therapeutics SEC Filings 7046 10-K: Annual report which provides a comprehensive overview of the company for the past year https://ir.neontherapeutics.com/sec-filings/sec-filing/10-k/0001694187-19-000026 Neon Therapeutics, Inc. Mon, 11 Mar 2019 17:29:03 -0400 Neon Therapeutics SEC Filings 7041 8-K: Report of unscheduled material events or corporate event https://ir.neontherapeutics.com/sec-filings/sec-filing/8-k/0001694187-19-000018 Neon Therapeutics, Inc. Mon, 11 Mar 2019 08:44:30 -0400 Neon Therapeutics SEC Filings 7036 3: Initial filing by director officer or owner of more than ten percent. https://ir.neontherapeutics.com/sec-filings/sec-filing/3/0001694187-19-000014 Neon Therapeutics, Inc. Fri, 01 Mar 2019 18:54:49 -0500 Neon Therapeutics SEC Filings 7016 4: Statement of changes in beneficial ownership of securities https://ir.neontherapeutics.com/sec-filings/sec-filing/4/0001694187-19-000015 Neon Therapeutics, Inc. Fri, 01 Mar 2019 18:54:48 -0500 Neon Therapeutics SEC Filings 7011